Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years (Q33756785)

29 July 2017

Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years (English)

1 reference

29 July 2017

0 references

cervix uterine cancer

1 reference

Suzanne Dyer

6

0 references

Megan Smith

Megan Smith

4

0 references

Jie-Bin Lew

Jie-Bin Lew

2

0 references

Sarah Lord

Sarah Lord

7

0 references

Karen Canfell

8

Karen Canfell

1 reference

29 July 2017

5

Kirsten Howard

1 reference

29 July 2017

1

Prudence Creighton

1 reference

29 July 2017

3

Mark Clements

1 reference

PubMed ID

21110881

29 July 2017

language of work or name

English

0 references

publication date

26 November 2010

1 reference

29 July 2017

1 reference

29 July 2017

10

1 reference

29 July 2017

734

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2458-10-734

29 July 2017

0 references

cites work

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001736

Models of cervical screening in the era of human papillomavirus vaccination

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001736

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001736

The predicted impact of vaccination on human papillomavirus infections in Australia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001736

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001736

Should the Pap smear be repeated at the first colposcopy visit?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001736

The predicted effect of changes in cervical screening practice in the UK: results from a modelling study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001736

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001736

The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2458-10-734

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001736

Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3001736

Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21110881

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High-grade cervical abnormalities and screening intervals in New South Wales, Australia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21110881

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21110881

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2458-10-734

1 reference

PubMed ID

21110881

Dimensions Publication ID

29 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2458-10-734

9 September 2019

1 reference

29 July 2017

1 reference

PubMed ID

21110881